Increased Expression of p-GSK3β Predicts Poor Survival in T –III/IV Stage OSCC Patients

Background/Aim: Glycogen synthase kinase 3 beta (GSK3-β) acts either as a tumor suppressor or an oncogene in various human cancers. The present study aimed to investigate the expression and activity of p-GSK3-β (Ser9) in oral cancer patients. Materials and Methods: We investigated the levels of p-GS...

Full description

Saved in:
Bibliographic Details
Published in:In Vivo
Main Authors: VELMURUGAN, BHARATH KUMAR, CHIU, CHUN-WEN, LIN, YUEH-MIN, BHARATH, MAHALAKSHMI, YEH, CHUNG-MIN, CHEN, YU-EN, CHUNG, CHIA-MIN, LIN, SHU-HUI
Format: Artigo
Language:Inglês
Published: International Institute of Anticancer Research 2020
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7439907/
https://ncbi.nlm.nih.gov/pubmed/32606150
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11975
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items